Abstract

Compounding Challenges for Immunocompromised Patients

Author(s): McElhiney Linda F

Issue: Nov/Dec 2008 - Arthritis and Immunological Diseases

Page(s): 482-487

Download in electronic PDF format for $75
  • Compounding Challenges for Immunocompromised Patients Page 1
  • Compounding Challenges for Immunocompromised Patients Page 2
  • Compounding Challenges for Immunocompromised Patients Page 3
  • Compounding Challenges for Immunocompromised Patients Page 4
  • Compounding Challenges for Immunocompromised Patients Page 5
  • Compounding Challenges for Immunocompromised Patients Page 6

Abstract

Compounding pharmacists play a vital role in the prevention, duration, and conclusion of diseases and infections for immunocompromised patients. Caused by deficiencies such as the human immunodeficiency virus, acquired immunodeficiency virus and cancers, which warrant immunosuppression during chemotherapy, immunodeficiency renders the patient vulnerable to viruses, infections, and diseases that, in the immunocompromised state, could develop lethally. By working closely with patients, compounding pharmacists are able to provide correct dosages, strengths, and drug combinations for each individual situation.

Related Keywords

  • immune deficiency
  • HIV
  • immunocompromised
  • immunosuppression
  • human immunodeficiency virus
  • AIDS
  • cancer chemotherapy
  • organ transplantation
  • bone marrow transplant
  • stem cell transplant
  • opportunistic infections
  • antifungal agents
  • antibiotics
  • antimicrobial agents
  • formulations

Related Categories

  • CANCER AND AIDS
  • FORMULATIONS
  • ALLERGY/IMMUNOLOGY/INFLAMMATION
  • DOSAGE FORMS/DRUG CARRIERS
  • INFECTIOUS DISEASE
  • PREVENTIVE MEDICINE/WELLNESS

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Nov/Dec 2008
Pg. 482-487
Compounding Challenges for Immunocompromised Patients
Author(s): McElhiney Linda F
Nov/Dec 2013
Pg. 446-450
Disguising the Taste of Antiretrovirals for Pediatric Patients Infected with Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome: Creative Flavor Compounding and Techniques, Part 2
Author(s): Horace Alexis E, Akbarian-Tefagh Jessica
Sep/Oct 2000
Pg. 334
Human Immunodeficiency Virus and the Acquired Immune Deficiency Syndrome
Author(s): Mathews Elizabeth
Mar/Apr 2004
Pg. 126-129
Basics of Compounding for the Treatment of Warts
Author(s): Allen Loyd V Jr
Mar/Apr 2006
Pg. 141
Mycophenolate Mofetil 50-mg/mL Oral Liquid
Author(s): Allen Loyd V Jr
Nov/Dec 2022
Pg. 446-466
Compounding with Biotechnology Products, Part 2: Product-specific Considerations
Author(s): Allen Loyd V Jr
Sep/Oct 2013
Pg. 388-391
Disguising the Taste of Antiretrovirals for Pediatric Patients Infected with Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome: Creative Flavor Compounding and Techniques, Part 1
Author(s): Horace Alexis E, Akbarian-Tefagh Jessica
Jul/Aug 2000
Pg. 264-272
Providing Positive Outcomes through Compounding for Animal Cancer Patients
Author(s): Davidson Gigi S
May/Jun 2004
Pg. 181-185
Compounding in the Pharmacy Curriculum: Beyond the Basics
Author(s): Hinkle Amanda R, Newton Gail D
Mar/Apr 2010
Pg. 112-115
Case Report: The Use of Inhaled Cyclosporine to Treat Bronchiolitis Obliterans Syndrome in a Lung Transplant Patient
Author(s): McElhiney Linda F
Sep/Oct 2014
Pg. 370-377
Autologous Serum Eye Drops for Severe Dry Eye Syndrome in a Patient with Chronic Graft-vs-Host Disease: A Case Report
Author(s): Mixon Bill, Mixon Jan, Isbey Edward K III, Sprinkle Shari
Jan/Feb 2004
Pg. 16-21
Androgen Deficiency in Women: Understanding the Science, Controversy and Art of Treating Our Patients - Part 1
Author(s): Cutter Christopher B
Jan/Feb 2012
Pg. 22-33
Oral Mucositis: Etiology and Clinical and Pharmaceutical Management
Author(s): Zur Eyal
Jan/Feb 2021
Pg. 45
Cyclophosphamide 10 mg/mL in Oral-Plus or Simple Syrup Suspension
Author(s): Allen Loyd V Jr
May/Jun 2021
Pg. 234
Tacrolimus 0.5 mg/mL in Ora-Plus and Simple Syrup Suspension
Author(s): Allen Loyd V Jr
May/Jun 1997
Pg. 175
Antiemetic Injection for Cancer Chemotherapy
Author(s): Allen Loyd V Jr
Jan/Feb 2008
Pg. 62
Calculations: Compounding for Cancer Patients
Author(s): Stockton Shelly J
Mar/Apr 2004
Pg. 96-99
Androgen Deficiency in Women: Understanding the Science, Controversy and Art of Treating Our Patients - Part 2
Author(s): Cutter Christopher B
Jul/Aug 2011
Pg. 316-319
Folinic Acid, L-DOPA, and 5-hydroxytryptophan in Tetrahydrobiopterin Deficiency: Treatment Plan for a Pediatric Patient
Author(s): Bramwell Bethany
May/Jun 2013
Pg. 262-263
PostScription: The Pharmacist's Role in the Treatment of Cancer: A Personal Plea and Testimonial
Author(s): Williams LaVonn A